Results 81 to 90 of about 9,655 (274)

Copeptin-based diagnosis of diabetes insipidus

open access: yesSwiss Medical Weekly, 2020
Polyuria-polydipsia syndrome consists of the three main entities: central or nephrogenic diabetes insipidus and primary polydipsia. Reliable distinction between these diagnoses is essential as treatment differs substantially, with the wrong treatment potentially leading to serious complications.
Julie Refardt, Mirjam Christ-Crain
openaire   +3 more sources

Combined measurements of plasma copeptin and troponin-I levels for early exclusion of acute myocardial infarction

open access: yesEgyptian Journal of Critical Care Medicine, 2016
Background: Acute myocardial infarction (AMI) is an acute stress state in which plasma copeptin rises. The combination of copeptin and troponin has been suggested to improve the diagnostic performance of acute MI in chest pain patients at time of ...
Walid Omar Ahmed   +3 more
doaj   +1 more source

Copeptin: a potential blood biomarker for acute ischemic stroke

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
Background Copeptin is a new blood biomarker for acute ischemic stroke which emerged to assist clinicians with decision-making. Serum copeptin can accurately reflect vasopressin concentration, which plays a role in aggravation of inflammatory responses ...
Mohammed I. Oraby   +3 more
doaj   +1 more source

Precision Diagnostics in Sports‐Related Traumatic Brain Injury: Pathophysiology, Biomarker Development and Emerging Technologies

open access: yesAdvanced Sensor Research, Volume 4, Issue 12, December 2025.
Sports‐related traumatic brain injuries (TBIs) remain underdiagnosed, within amateur athletic cohorts. This review critically synthesises recent advancements in AI‐assisted neuroimaging, blood‐based biomarker profiling, wearable biosensing platforms for early detection, injury stratification, and longitudinal surveillance of TBIs.
Daniel Nicol   +3 more
wiley   +1 more source

Re‐PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients

open access: yesESC Heart Failure, Volume 12, Issue 6, Page 4495-4502, December 2025.
Abstract Aims Renal impairment frequently coexists with heart failure (HF) and is associated with increased risk of poor clinical outcomes. This highlights the urgent need for therapies targeting both cardiac and renal dysfunction. AZD3427, a long‐acting recombinant fusion protein and relaxin analogue that selectively activates the relaxin family ...
Marcin Ufnal   +9 more
wiley   +1 more source

Copeptin reliably reflects longitudinal right ventricular function

open access: yesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2021
Background Data is limited evaluating novel biomarkers in right ventricular dysfunction. Normal right heart function improves the prognosis of patients with heart failure. Therefore, this study investigates the association between the novel biomarker copeptin and right heart function compared to NT-proBNP.
Melissa Harbrücker   +15 more
openaire   +3 more sources

Predictive value of copeptin as a severity marker of community-acquired pneumonia

open access: yesElectronic Physician, 2017
Background: Pneumonia is the leading cause of death in children. Few studies have explored the predictive value of copeptin in pediatric pneumonia.
Gamal Baheeg Mohamed   +4 more
doaj   +1 more source

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival

open access: yesCritical Care, 2017
Background Acute-on-chronic liver failure (ACLF) is characterized by the presence of acute decompensation (AD) of cirrhosis, organ failure, and high short-term mortality rates.
Annarein J. C. Kerbert   +11 more
doaj   +1 more source

Cardiac response to chronic restraint stress involves mineralocorticoid receptors in male Sprague–Dawley rats

open access: yesPhysiological Reports, Volume 13, Issue 19, October 2025.
Abstract In the present study, we aimed at elucidating whether exposure to chronic stress affects the expression of cardiac mineralocorticoid receptors (MRs), whether it influences cardiac structure and function, and whether MRs blockade attenuates the stress‐induced changes.
D. Sztechman   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy